Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity

Autor: Gislaine Candida Batista Jorge, Sérgio Henrique Sousa Santos, Erivelton Pereira dos Santos, Alfredo Maurício Batista De-Paula, André Luiz Sena Guimarães, Antonio Sergio Barcala Jorge, Ludmilla Regina de Souza, João Marcus Oliveira Andrade, Alanna Fernandes Paraíso, Christine Mendes Silveira
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Adult
Male
medicine.medical_specialty
Endocrinology
Diabetes and Metabolism

Tecido adiposo
Adipose tissue
Bariatric Surgery
White adipose tissue
Intra-Abdominal Fat
Severity of Illness Index
Body Mass Index
03 medical and health sciences
Young Adult
0302 clinical medicine
Non-alcoholic Fatty Liver Disease
Internal medicine
medicine
Humans
Prospective cohort study
Índice de massa corporal
Nutrition and Dietetics
business.industry
Class III obesity
Interleukin-6
Tumor Necrosis Factor-alpha
Gene Expression Profiling
Fatty liver
nutritional and metabolic diseases
Citocinas
Middle Aged
medicine.disease
Obesity
Morbid

030104 developmental biology
Endocrinology
Cross-Sectional Studies
Obesidade
030211 gastroenterology & hepatology
Female
Steatosis
Steatohepatitis
Inflammation Mediators
business
Fígado - Doenças
Body mass index
Biomarkers
Zdroj: Repositório Institucional da UFMG
Universidade Federal de Minas Gerais (UFMG)
instacron:UFMG
Popis: CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Objectives: to analyze the mRNA expression of interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-α) in the liver and white adipose tissue samples of individuals with class III obesity (body mass index ≥40.0 kg/m2) with non-alcoholic fatty liver disease (NAFLD). Methods: this cross-sectional study included patients with class III obesity exhibiting early or late morphological presentation of NAFLD (non-alcoholic hepatic steatosis [NAFL], n = 8 and non-alcoholic steatohepatitis [NASH], n = 13, respectively). All patients underwent bariatric surgery and peripheral blood, liver, and visceral white adipose tissue (WAT) samples were collected. Socio-demographic, anthropometric, clinical, plasma biochemical, and nutritional characteristics of each study subject were assessed and compared between patients presenting with NAFL and NASH. IL-6 and TNF-α mRNA expression in the liver and WAT samples were measured by using quantitative real time-polymerase chain reaction (qRT-PCR). Results: individuals with class III obesity and NASH showed higher body mass index (BMI) and higher IL-6 and TNF-α mRNA expression in the WAT compared to that of patients with NAFL (p = 0.01, for all associations). Conclusions: individuals with class III obesity with higher morphological severity of NAFLD exhibited higher BMI and higher IL-6 and TNF-α expression in the WAT. Future prospective studies are warranted to determine how BMI, IL-6, and TNF-α affect the progression of NAFLD in individuals with class III obesity.
Databáze: OpenAIRE